Search
ChatPaper
AI Writing
analysis
Analysis
编组
Open Data
more
More
RankingsMust ReadingJournal&ConferenceAI TRAI HistoryMaster Reading TreeXiaomai's Star TalentsTrajectoryTalentNDI TrackerAI sign LanguageOpen
VIPCreated with Sketch.
Research Interests

Papers共 33 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
KARAKTERISASI MINYAK LAVENDER (Lavandula angustifolia) UNTUK ALTERNATIF BAHAN AKTIF SEDIAAN FARMASI
Hepy Nuriska,Dina Mulyanti,Ratih Aryani
Bandung Conference Series: Pharmacypp.483-486, (2023)
Cited0Views0Bibtex
0
0
Karakterisasi minyak eukaliptus untuk alternatif bahan utama sediaan farmasi
Vina Azzahra Siti Nurhedian,Dina Mulyanti,Sani Ega Priani
Bandung Conference Series Pharmacypp.362-366, (2023)
Cited0Views0Bibtex
0
0
Aspek Bioteknologi dan Kehalalan Kopi Luwak serta Korelasi Manfaatnya untuk Kesehatan
Rezza Marcella,Dina Mulyanti
Jurnal Riset Farmasipp.66-74, (2022)
Cited0Views0Bibtex
0
0
Kajian Potensi Penyebaran Mikroorganisme Patogen Penyebab ISPA dan Diare Berdasarkan Kondisi Geografis dan Demografis Wilayah Indonesia
Erica Yola Pramana Putri,Dina Mulyanti, Evi Umayah
Bandung Conference Series: Pharmacyno. 2 (2022)
Cited0Views0Bibtex
0
0
Studi Literatur Potensi Pengembangan Produk Biosimilar untuk Pengobatan Penyakit Tidak Menular di Indonesia
Gizca Ratna Tazkia,Dina Mulyanti
Bandung Conference Series: Pharmacyno. 2 (2022)
Cited0Views0Bibtex
0
0
Studi Literatur Titik Kritis Kehalalan pada Alat Kesehatan
Nurul Azmi Firdiyani,Dina Mulyanti,Anan Suparman
Bandung Conference Series: Pharmacyno. 2 (2022)
Cited0Views0Bibtex
0
0
Load More
Author Statistics
  • 合作者
  • 学生
  • 导师
No result temporarily, you can search similar Scholar with the same research interest
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn